The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

PHASE3CompletedINTERVENTIONAL
Enrollment

7,741

Participants

Timeline

Start Date

November 3, 2023

Primary Completion Date

March 5, 2024

Study Completion Date

January 30, 2025

Conditions
Influenza, Human
Interventions
BIOLOGICAL

Investigational aQIVc

Investigational Adjuvanted Cell-derived Quadrivalent Influenza vaccine, containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO (World Health Organization) for quadrivalent vaccines for the respective season.

BIOLOGICAL

licensed QIVr

Recombinant Quadrivalent Influenza Vaccine (Flublok Quadrivalent/Supemtek) containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO for quadrivalent vaccines for the respective season.

BIOLOGICAL

licensed aQIV

Adjuvanted, egg-derived Quadrivalent Influenza Vaccine (Fluad) containing four influenza virus strains (A/H1N1, A/H3N2, B/Yamagata and Victoria lineage) recommended by the WHO for quadrivalent vaccines for the respective season.

Trial Locations (96)

1642

Ospital ng Makati, City of Taguig

2650

Amager-Hvidovre Hospital, Hvidovre

4000

Zealand University Hospital, Roskilde, Roskilde

10117

OÜ Innomedica, Tallinn

Klinische Forschung Berlin-Mitte GmbH, Berlin

10128

Center for Clinical and Basic Research, Tallinn

10617

Al Mare Perearstikeskus OÜ, Tallinn

Merelahe Family Doctors Centre, Tallinn

10629

emovis GmbH, Berlin

10787

Velocity Clinical Research, Berlin, Berlin

13057

Velocity Clinical Research, Syracuse, East Syracuse

13850

Velocity Clinical Research, Vestal, New York

13905

Velocity Clinical Research, Binghamton, Binghamton

19055

Klinische Forschung Schwerin GmbH, Schwerin

20253

Klinische Forschung Hamburg GmbH, Hamburg

20854

Velocity Clinical Research Rockville, Rockville

21075

Centennial Medical Group, PC, Columbia

22143

Velocity Clinical Research, Hamburg, Hamburg

23435

Velocity Clinical Research, Suffolk, Suffolk

27612

M3 Wake Research, Inc, Raleigh

29303

Velocity Clinical Research, Spartanburg, Spartanburg

29340

Velocity Clinical Research, Gaffney, Gaffney

30159

Klinische Forschung Hannover-Mitte GmbH, Hanover

32132

Velocity Clinical Research, New Smyrna Beach, Edgewater

33016

Global Health Research Center, Miami Lakes

33126

USA and International Research Inc., Doral

33351

Precision Clinical Research, Sunrise

33458

Health Awareness, Inc., Jupiter

33615

Global Health Research center, Tampa

33756

Innovative Research of West Florida, Inc., Clearwater

33777

ARS - Lake Oconee, Largo

37203

Clinical Research Associates, Inc., Nashville

37909

AMR-Knoxville, Knoxville

39503

Velocity Clinical Research Gulfport, Gulfport

44122

Velocity Clinical Research, Cleveland, Cleveland

45212

CTI Clinical Research Center, Cincinnati

45242

Velocity Clinical Research Cincinnati, Cincinnati

45355

Klinisches Forschungszentrum Dr. Hagemann am Hausarztzentrum am Germaniaplatz Dr.Hagemann/ Breider, Essen

Studienzentrum Bocholderstrasse, Essen

45359

UHZ Klinische Forschung, Essen

46383

Velocity Clinical Research Valparaoso, Valparaiso

50106

Clinical Research Centre, Tartu

50411

Tartu University Hospital, Tartu

51106

Velocity Clinical Research, Sioux City, Sioux City

55128

Research Quist, Mainz

60031

Great Lakes Clinical Trials, LLC. Ravenswood dba Flourish Research, Gurnee

60640

Great Lakes Clinical Trials, LLC Ravenswood dba Flourish Research, Chicago

63141

Sundance Clinical Research, St Louis

64114

Alliance for Multispecialty Research, LLC, Kansas City

68134

Velocity Clinical Research, Omaha, Omaha

68701

Velocity Clinical Research, Norfolk, Norfolk

70006

Benchmark Research, Metairie

70178

Studienzentrum Leitz Triderm, Stuttgart

70809

Velocity Clinical Research, Baton Rough, Baton Rouge

71201

IMA Evaluations LLC, Monroe

72205

Baptist Health Center for Clinical Research, Little Rock

72713

Vee Family Doctor's Center OY, Paide

74800

The Aga Khan University, Karachi

75024

ACRC trials Parent HQ, Plano

75251

Cedar Health Research, LLC, Dallas

76135

Benchmark Research, Fort Worth

76137

Klinische Forschung Karlsruhe GmbH, Karlsruhe

77065

DM Clinical Research - Martin Diagnostic Clinic, Houston

77375

DM Clinical Research, Tomball

83642

Velocity Clinical Research- Boise, Meridian

84088

Velocity Clinical Research, Salt Lake City, West Jordan

84107

BBCR Holdings LLC dba JBR Clinical Research - Midvale Campus, Salt Lake City

85281

Alliance for Multispecialty Research (AMR) Phoenix, Tempe

89119

Alliance for Multispecialty Research (AMR) LLC, Las Vegas, Las Vegas

92647

Marvel Clinical Research, Huntington Beach

96001

Paradigm Clinical Research Center, LLC, Redding

97504

Velocity Clinical Research - Medford, Medford

06460

Clinical Research Consulting, Inc., Milford

06708

Chase Medical Research, LLC, Waterbury

02818

Velocity Clinical Research-Providence, East Greenwich

T4P1K4

CARe Clinic, Red Deer

01069

Klinische Forschung Dresden GmbH, Dresden

04177

Velocity Clinical Research, Leipzig, Leipzig

04179

Studienzentrum FMZ Radowsky, Leipzig

Unknown

Central Park Teaching Hospital, Lahore

Silang Specialists Medical Center, Silang

Davao Medical School Foundation Inc. Hospital / NEMESIO F. ANLOCOTAN III, Davao City

Las Pinas Doctors Hospital, Las Piñas

Marilao Saint Michael Family Hospital, Inc, Bulacan

CARE CT Group Inc. CARE Clinical Trials, Cavite

Health Index Multispecialty and Lying in Clinic, Cavite

Norzel Medical and Diagnostic Clinic, Cebu City

West Visayas State University Medical Center, Iloilo City

Manila Doctors Hospital, Manila

Mary Johnston Hospital, Manila

Quirino Memorial Medical Center, Quezon City

HP112QW

Velocity High Wycombe, High Wycombe

N128BU

Velocity North London, London

PR29RB

Panthera Biopartners Ltd (Preston), Preston

OL114AU

Panthera Biopartners Ltd (Manchester), Rochdale

S25FX

Panthera Biopartners (Sheffield), Sheffield

All Listed Sponsors
lead

Seqirus

INDUSTRY

NCT06015282 - The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older | Biotech Hunter | Biotech Hunter